SARS-Cov-2 variants in mink: rapid assessment published

Written by Embio Diagnostics

November 12, 2020

EFSA’s animal health specialists have contributed to a rapid assessment of the risks to human health from the new SARS-CoV-2 variants related to mink.

The assessment, published today by the European Centre for Disease Prevention and Control, contains a number of recommendations aimed at protecting public health.

Nikolaus Kriz, head of EFSA’s Animal Health and Welfare Unit, said: “While the risk of cross-border spread of these SARS-CoV-2 variants through animals and their products is very low, it is important that people avoid close contact with farmed mink. Additional surveillance measures are necessary to limit further spread.”

The assessment was carried out after Denmark reported 214 cases of humans infected with SARS-CoV-2 variants related to mink.

https://www.efsa.europa.eu/en/news/sars-cov-2-variants-mink-rapid-assessment-published

You May Also Like…

About Us.

EMBIO Diagnostics (EMBIO) designs and develops custom based hardware solutions and consults as an expert in the biotechnology at a global scale.

Follow the developments.

 

Contact us

Get In Touch

Cyprus

(+357) 22515175
info@embiodiagnostics.eu
M-F: 9am-6pm

Athalassas Avenue 8B,2018, NIcosia

USA

(+001) 973 876 1792

sales@embiodiagnostics.eu